$ARQQ

Leaver Andrew sold $58K of ARQQ

Leaver Andrew (Chief Executive Officer) sold 2,398 shares of Arqit Quantum Inc. (ARQQ) at $24.19 on 2026-10-06.

Original reporting
SEC EDGAR · Leaver Andrew
Published Oct 8, 2026, 10:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 10:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ARQQ
Bearish
medium confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQBearishLow
01

Why it matters

The filing provides the first public detail of the CEO's share sale, which may modestly affect sentiment.

02

Market read

A modest insider sell by the CEO is unlikely to move ARQQ significantly but could create slight downside bias.

03

What to watch

CEO still retains a large stake; the transaction size is small relative to total holdings.

Relevance 3/10Novelty 3/10Timing: same-day filing

Background

SEC Form 4 filing discloses an insider transaction by ARQQ's CEO.

Company-level read

Ticker impact

$ARQQBearishMedium confidence
Context

CEO Leaver Andrew sold 2,398 shares for $58,011, reducing his holding to 51,330 shares.

Expected impact

minor pressure as market prices in the modest insider sell

Evidence & confidence

The sale is small relative to holdings but signals a CEO liquidity move, which can be viewed as slightly bearish.

Market effects

Quantum communications sector sees limited impact from this modest insider sale.

US equity market

Limited

Counterpoint

The sale could be routine liquidity need and not a bearish signal.

Key entities

  • Leaver Andrew

    Chief Executive Officer of Arqit Quantum Inc.

  • Arqit Quantum Inc.

    Quantum communications firm listed on Nasdaq under ticker ARQQ.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).